Multicenter experience with metallic ureteral stents for malignant and chronic benign ureteral obstruction

Journal of Endourology

Volumn 24, Issue 7, 2010, Pages 1189-1193

  Modi, Achal P ^a   Ritch, Chad R ^b   Arend, David ^a   Walsh, Rhonda M ^b   Ordonez, Maria ^b   Landman, Jaime ^b   Gupta, Mantu ^b   Knudsen, Bodo E ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; FOLLOW UP; HUMAN; HYDRONEPHROSIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PERCUTANEOUS NEPHROLITHOTOMY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URETER OBSTRUCTION; URETER STENT;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; HUMANS; MIDDLE AGED; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; STENTS; URETERAL NEOPLASMS; URETERAL OBSTRUCTION;

EID: 77954935583     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2010.0121     Document Type: Article

References (14)

1. Ganatra AM, Loughlin KR. The management of malignant ureteral obstruction treated with ureteral stents. J Urol 2005:174:2125-2128.
2. Shekarriz B, Shekarriz H, Upadhyay J, et al. Outcome of palliative urinary diversion in the treatment of advanced malignancies. Cancer 1999;85:998-1003.
3. Chung SY, Stein RJ, Landsittel D, et al. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents. J Urol 2004;172:592-595.
4. Wollin TA, Tieszer C, Riddell JV, et al: Bacterial biofilm formation, encrustation, and antibiotic adsorption to ureteral stents indwelling in humans. J Endourol 1998;12:101-111.
5. Joshi H, Chitale S, Nagarajan M, et al. A prospective randomized single-blind comparison of ureteral stents composed of firm and soft polymer. J Urol 2005;174:2303-2306.
6. Liatsikos EN, Karnabatidis D, Katsanos K, et al. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment. J Urol 2009;182:2613-2617.
7. Wong LM, Cleeve LK, Milner AD, Pitman AG. Malignant ureteral obstruction: outcomes after intervention. Have things changed? J Urol 2007;178:178-183.
8. Feng MI, Bellman GC, Shapiro CE. Management of ureteral obstruction secondary to pelvic malignancies. J Endourol 1999;13:521-524.
9. Hafron J, Ost MC, Tan BJ, et al. Novel dual-lumen ureteral stents provide better ureteral flow than single ureteral stent in ex vivo porcine kidney model of extrinsic ureteral obstruction. Urology 2006;68:911-915.
10. Lingam K, Paterson PJ, Lingam MK, et al. Subcutaneous urinary diversion: An alternative to percutaneous ne-phrostomy. J Urol 1994;152:70-72.
11. Liu JS, Hrebinko RL. The use of 2 ipsilateral ureteral stents for relief of ureteral obstruction from extrinsic compression. J Urol 1998;159:179-181.
12. Nagele U, Kuczyk MA, Horstmann M, et al. Initial clinical experience with full-length metal ureteral stents for obstructive ureteral stenosis. World J Urol 2008;26:257-262.
13. Liatsikos E, Kallidonis P, Kyriazis I, et al. Ureteral obstruction: Is the full metallic double-pigtail stent the way to go? Eur Urol 2010:57:480-486.
14. Cook Medical: Ureteral Stent Drainage: A Comparative Study of Flow Through Ureteral Stents. Unpublished data.